A proposed bailout for A-T patients?

European Journal of Neurology

Volumn 16, Issue 6, 2009, Pages 653-655

  Gatti, Richard A ^a   Perlman, Susan ^b  

^a Laboratory Medicine ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ATM PROTEIN; BETAMETHASONE; GLUCOCORTICOID; METHYLPREDNISOLONE; PROTEIN SERINE THREONINE KINASE;

ASTHMA; ATAXIA TELANGIECTASIA; ATM GENE; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DOUBLE STRANDED DNA BREAK; DRUG EFFECT; DRUG WITHDRAWAL; EDITORIAL; GENE; GENE MUTATION; GENETIC CODE; HUMAN; IMMUNE RESPONSE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; SLURRED SPEECH; WESTERN BLOTTING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AGE FACTORS; ATAXIA TELANGIECTASIA; BETAMETHASONE; CELL CYCLE PROTEINS; CEREBELLUM; CLINICAL TRIALS AS TOPIC; DNA-BINDING PROTEINS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSION; OXIDATIVE STRESS; PROTEIN-SERINE-THREONINE KINASES; RISK ASSESSMENT; TIME; TIME FACTORS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEINS;

EID: 65449186209     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02597.x     Document Type: Editorial

References (37)

1. Buoni S, Zanolli R, Sorrentino L, Fois A. Betamethasone and improvement of neurological symptoms in ataxia-telangiectasia. Arch Neurol 2006 63 : 1479 1482. (Pubitemid 44547562)
2. Broccoletti T, Del Giudice E, Amorosi S, et al. Steroid-induced improvement of neurological signs in ataxia-telangiectasia patients. Eur J Neurol 2008 15 : 223 228.
3. Russo I, Cosentino C, Del Giudice E, et al. In ataxia-teleangiectasia betamethasone response is inversely correlated to cerebellar atrophy and directly to antioxidative capacity. Eur J Neurol 2009 16 : 755 759.
4. Boder E. Ataxia-telangiectasia: an overview. In : Gatti RA, Swift M, eds. Ataxia-telangiectasia: Genetics, Neuropathology, and Immunology of a Degenerative Disease of Childhood. Kroc Conference Series. Vol. 19. New York : Alan R. Liss Inc, 1985 : 1 63.
5. Gatti RA. Ataxia-telangiectasia. In : Scriver CR, Beaudet A, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. Edition 8. New York : Publ. McGraw-Hill, Inc, 2001 : 705 732.
6. Perlman S, Becker-Catania S, Gatti RA. Ataxia-telangiectasia: diagnosis and treatment. Semin Pediatr Neurol 2003 10 : 173 182. (Pubitemid 37414093)
7. Chun HH, Gatti RA. Ataxia-telangiectasia, an evolving phenotype. DNA Repair 2004 3 : 1187 1196. (Pubitemid 38997962)
8. Mitui M, Nahas SA, Chun HH, Gatti RA. Diagnosis of ataxia-telangiectasia: ATM mutations associated with cancer. In : Nakamura R, Grody W, Wu S, Nagle D eds. Cancer Diagnostics: Current and Future Trends. : Humana Press, Totowa, NJ, 2004 : 473 487.
9. Nahas SA, Butch AW, Gatti RA. Rapid flow cytometry-based SMC1 phosphorylation assay for identification of ataxia-telangiectasia homozygotes and heterozygotes. Clin Chem 2009 55 : 463 472.
10. Gatti RA. Concluding discussion. In : Gatti RA, Swift M, eds. Ataxia-telangiectasia: Genetics, Neuropathology, and Immunology of a Degenerative Disease of Childhood. Kroc Conference Series. Vol. 19. New York : Alan R. Liss, Inc., 1985 : 357 371.
11. Oxelius V-A, Berkel AI, Hanson LA. IgG2 deficiency in ataxia-telangiectasia. N Engl J Med 1982 306 : 515 520. (Pubitemid 12175744)
12. Gatti RA, Bick M, Tam CF, et al. Ataxia-telangiectasia: a multiparameter analysis of eight families. Clin Immunol Immunopathol 1982 23 : 501 516. (Pubitemid 12093019)
13. Woods CG, Taylor AMR. Ataxia telangiectasia in the British Isles: the clinical and laboratory features of 70 affected individuals. Q J Med New Series 1992 298 : 169 179.
14. Regueiro JR, Porras O, Lavin M, Gatti RA. Ataxia-telangiectasia. A pimary immunodeficiency revisited. Immunol Allergy Clin North Am 2000 20 : 177 206.
15. Sanal O, Ozbas-Gerceker F, Yel L, et al. Defective anti-polysaccharide antibody response in patients with ataxia-telangiectasia. Turk J Pediatr 2004 46 : 208 213. (Pubitemid 39276576)
16. Pashankar F, Singhal V, Akabogu I, Gatti RA, Goldman FD. Intact T cell responses in ataxia telangiectasia. Clin Immunol 2006 120 : 158 162. (Pubitemid 44080681)
17. Lou Z, Minter-Dykhouse K, Franco S, et al. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol Cell 2006 21 : 187 200. (Pubitemid 43099935)
18. Morales JC, Franco S, Murphy MM, et al. 53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis. Proc Natl Acad Sci USA 2006 103 : 3310 3315. (Pubitemid 43346466)
19. Franco S, Alt FW, Manis JP. Pathways that suppress programmed DNA breaks from progressing to chromosomal breaks and translocations. DNA Repair 2006 5 : 1030 1041. (Pubitemid 44308467)
20. Zha S, Sekiguchi J, Brush JW, Bassing CH, Alt FW. Complementary functions of ATM and H2AX in development and suppression of genomic instability. Proc Natl Acad Sci USA 2008 105 : 9302 9306.
21. Bassing cH, Ranganath S, Murphy M, Savic V, Gleason M, Alt FW. Aberrant V(D)J recombination is not required for rapid development of H2AX/p53-deficient thymic lymphomas with clonal translocations. Blood 2008 111 : 2163 2169.
22. Goodarzi AA, Noon AT, Deckbar D, et al. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol Cell 2008 31 : 167 177.
23. Mitzuoka S, Ballif BA, Smogorzewska A, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007 316 : 1160 1166. (Pubitemid 46877472)
24. Lee Y, Chong MJ, McKinnon PJ. Ataxia telangiectasia mutated-dependent apoptosis after genotoxic stress in the developing nervous system is determined by cellular differentiation status. J Neurosci 2001 21 : 6687 6693. (Pubitemid 32781113)
25. Maclean KH, Kastan MB, Cleveland JL. ATM deficiency affects both apoptosis and proliferation to augment myc-induced lymphomagenesis. Mol Cancer Res 2007 5 : 705 711.
26. Walkley CR, Qudsi R, Sankaran VG, et al. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev 2008 22 : 1662 1676.
27. Gaul L, Mandl-Weber S, Baumann P, Emmerich B, Schmidmaier R. Bendamustine induces G2 cell cycle arrent and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathways. J Cancer Res Clin Oncol 2008 134 : 245 253. (Pubitemid 350234070)
28. Yoshida K, Ozaki T, Furuya K, et al. ATM-dependent nuclear accumulation of IKK-alpha plays an important role in the regulation of p73-mediated apoptosis in response to cisplatin. Oncogene 2008 27 : 1183 1188.
29. Stahn C, Lowenberg M, Hommes DW, Buttgereit F. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol 2007 275 : 71 78. (Pubitemid 47259281)
30. Barzilai A, Rotman G, Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair 2002 1 : 3 25. (Pubitemid 34475690)
31. Ceccatelli S, Tamm C, Zhang Q, Chen M. Mechanisms and modulation of neural cell damage induced by oxidative stress. Physiol Behav 2007 92 : 87 92. (Pubitemid 47374239)
32. Schulz JB, Lindenau J, Seyfried J, Dichganx J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 2000 267 : 4904 4911. (Pubitemid 30641286)
33. Lavin MF, Gueven N, Bottle S, Gatti RA. Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia. Br Med Bull 2007 10 : 1 19.
34. Lai C-H, Chun HH, Nahas SA, et al. Correction of ATM gene function by aminoglycoside-induced readthrough of premature termination codons. Proc Natl Acad Sci USA 2004 101 : 15676 15681. (Pubitemid 39473547)
35. Du L, Pollard J, Gatti RA. Correction of prototypic ATM splicing mutation and aberrant ATM function with antisense morpholino oligonucleotides. Proc Natl Acad Sci USA 2007 104 : 6007 6012. (Pubitemid 47175649)
36. Hu H, Gatti RA. New approaches to treatment of primary immune deficiencies: fixing mutations with chemicals. Curr Opin Allergy Clin Immunol 2008 8 : 540 546.
37. Gatti RA, Vinters HV. Cerebellar pathology in ataxia-telangiectasia: the significance of basket cells. in : Gatti RA, Swift M, eds. Ataxia- telangiectasia: Genetics, Neuropathology, and Immunology of a Degenerative Disease of Childhood. Vol. 19. New York : Alan R Liss Inc, 1985 : 225 232.